In response to "Histopathologic validation of 3'-deoxy-3'-(18)F-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice"

There is no fulltext present in this item.

Title:	In response to "Histopathologic validation of 3'-deoxy-3'-(18)F-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice"
Author(s):	Troost, E.G. ; Hoeben, B.A.W. ; Laverman, P. ; Bussink, J. ; Oyen, W.J.G.
Publication year:	2015
Source:	Radiotherapy and Oncology, vol. 114, iss. 3, (2015), pp. 417-418
ISSN:	0167-8140
DOI:	https://doi.org/10.1016/j.radonc.2015.11.040
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/153130
Display more details
Subject:	Radboudumc 19: Nanomedicine RIHS: Radboud Institute for Health Sciences Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Radiation Oncology Radiology & Nuclear Medicine
Journal title:	Radiotherapy and Oncology
Volume:	vol. 114
Issue:	iss. 3
Page start:	p. 417
Page end:	p. 418